![Alain Munoz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/03/2026
Alain H.
Munoz founded Amistad Pharma in 2000, where he is working as Chief Executive Officer from 2009.
Dr. Munoz also founded Science, Business & Management SARL, where he is working as Chief Executive Officer.
Dr. Munoz also currently works at Auris Medical AG, as Director from 2018, Altamira Therapeutics Ltd., as Independent Non-Executive Director from 2018, Amryt Pharma Ltd., as Non-Executive Director from 2019, and various other companies.
Dr. Munoz also formerly worked at Novagali Pharma SA, as Chairman-Supervisory Board from 2003 to 2011, Key Neurosciences SAS, as Chairman, Acticor Biotech SAS, as Chairman, and various other companies.
Dr. Munoz received his doctorate degree from Université de Montpellier, undergraduate degree from International Institute for Management Development, and graduate degree from Centre Hospitalier Universitaire Pitie-Salpetriere.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2025 | 0 ( -.--% ) | - $ | 31/03/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Direttore/Membro del Consiglio | 01/03/2018 |
| AMRYT PHARMA PLC | Direttore/Membro del Consiglio | 24/09/2019 |
Science, Business & Management SARL | Amministratore Delegato | - |
Intercell Austria AG | Direttore/Membro del Consiglio | - |
Amistad Pharma | Amministratore Delegato | 01/01/2000 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Direttore/Membro del Consiglio | 01/03/2018 |
| Società | Posizione | Fine |
|---|---|---|
| ZEALAND PHARMA A/S | Direttore/Membro del Consiglio | 20/03/2024 |
| CELLECTIS S.A. | Direttore/Membro del Consiglio | 31/12/2022 |
| ATON | Presidente | 01/07/2017 |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 38 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Manufactures human and animal vaccines | Health Technology |
Hybrigenics SA
 Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
GeneSystems SA
 GeneSystems SA Pharmaceuticals: MajorHealth Technology Develops and commercializes innovative biotechnology diagnostics products | Health Technology |
Université de Montpellier
 Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment | Health Technology |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Vivacta Ltd.
 Vivacta Ltd. Medical SpecialtiesHealth Technology Develops piezofilm-based chemical detection technology | Health Technology |
Centre Hospitalier Universitaire Pitie-Salpetriere
 Centre Hospitalier Universitaire Pitie-Salpetriere Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Genticel SA
 Genticel SA BiotechnologyHealth Technology Develops vaccines for patients infected with human papillomavirus | Health Technology |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Saint Jean Industries Lorraine SAS
 Saint Jean Industries Lorraine SAS Metal FabricationProducer Manufacturing Specializes in the design and the production of prototype parts | Producer Manufacturing |
Umecrine AB
 Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Commercial Services |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Centre Hospitalier Universitaire de Montpellier
 Centre Hospitalier Universitaire de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fournier Laboratories Ireland Ltd.
 Fournier Laboratories Ireland Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
Medesis SA | |
Amistad Pharma | |
Fournier Group, Inc.
 Fournier Group, Inc. Multi-Line InsuranceFinance Operates as commercial and personal lines retail insurance agency | Finance |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Auris Medical Holding AG /Old/
 Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
Science, Business & Management SARL | |
Medesis Pharma SA
 Medesis Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical biotechnology company that develops technology for the delivery of therapeutic molecules to treat diseases | Health Technology |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Acticor Biotech SAS
 Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
Altamira Therapeutics Ltd.
 Altamira Therapeutics Ltd. BiotechnologyHealth Technology Develops RNA therapeutics for inner ear disorders | Health Technology |
Intercell Austria AG | |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
